Abstract:Background: Type 2 diabetes mellitus (T2DM) is a risk factor for acute myocardial infarction (AMI) and a common comorbidity in patients with AMI. T2DM doubles the fatality rate of patients with AMI in the acute phase of AMI and the follow-up period. However, the mechanisms by which T2DM increases the fatality rate remain unknown. This study sought to investigate changes in the gut microbiota of patients with AMI and T2DM (AMIDM) to extend understandings of the relative mechanisms from the aspects of gut microbiota. Methods: Patients were recruited and divided into 2 groups comprising 15 patients with AMIDM and 15 patients with AMI but without T2DM (AMINDM). Their stool samples and clinical information were collected. 16S ribosomal DNA sequencing was used to analyze the structure and composition of the gut microbiota based on the operational taxonomic units. Results: A significant difference was observed in the gut microbiota β diversity between the 2 groups. At the phylum level, the AMIDM patients showed an increase in the abundance of Firmicutes and a decrease in the abundance of Bacteroidetes compared to the AMINDM patients. At the genus level, the AMIDM patients showed an increase in the abundance of Companilactobacillus, Defluvitaleaceae UCG-011 and UCG-009, and a decrease in the abundance of Phascolarctobacterium and CAG 56 compared to the AMINDM patients. At the species level, the AMIDM patients showed an increase in the abundance of species unclassified NK4A214 group, Bacteroides clarus, Coprococcus comes, unclassified Defluviltaleaceae UCG-011, uncultured rumen bacterium, unclassified CAG 56, Barnesiella intestinihominis, Lachnospiraceae bacterium, Bacteroides nordii, unclassified UCG-009, and the Family XIII AD3011 group compared to the AMINDM patients. The gut microbiota function predictions indicated that the nucleotide metabolism-related pathway was significantly more increase in the patients with AMIDM than those with AMINDM. Additionally, the patients with AMIDM showed an increase in gram-positive bacteria and a decrease in the proportion of gram-negative bacteria. Our correlation analysis results on the gut microbiota and clinical parameters might extend understandings of the progression of AMI. Conclusions: Changes in the gut microbiota composition of patients with AMIDM affect the severity of the metabolic disturbance and may be responsible for poorer clinical outcomes and worse disease progression in patients with AMIDM compared to those with AMINDM.

Changes of Blood Fat in Diabetic Patients in Early Phase of Acute Myocardial Infarction

Changes of Blood Pressure,blood Glucose and Blood Lipids Levels after Intensive Treatment in Incipient Diabetes II Patients

Blood Sugar Changes in Acute Myocardial Infarction Patients with or Without Diabetes Mellitus and Its Relationships with Heart Function

Changes of Th1/Th2 Cell Ratio in the Peripheral Blood of Patients with Both Coronary Heart Disease and Diabetes

Clinical Significance of the Changes of Plasma Adiponectin Levels in Patients with Coronary Artery Disease

Disparities of In-Hospital and Short Term Prognosis of Patients with No History of Diabetes in the Early =phase of Acute Myocardial Infarction

Preliminary Study on Insulin Resistance at the Early Stage in Patients of Acute Myocardial Infarction Without Previous History of Diabetes

Lipidomics Profile Changes of Type 2 Diabetes Mellitus with Acute Myocardial Infarction

Hyperglycemia Affects the Prognosis of Acute Myocardial Infarction

To explore the clinical significance of the early Acute myocardial infarction diagnosis by the Heart-type Fatty Acid-Binding Protein testing

Relationship between blood gluocose level on admission and prognosis in female patients with acute myocardial infarction

Effect of hemoglobin A1c change on 24-month clinical outcomes in patients with diabetes after acute myocardial infarction

Changes and Analysis of the Plasma Levels of B-type Natriuretic Peptide,d-Dimer, Fibrinogen in the Patients with Acute Myocardial Infarction

A Continuous Glycemic Observation During Early Phase of Acute Myocardial Infarction in Patients Without Known Diabetes Mellitus

Investigate the Clinical Characteristics of Patients with Acute Myocardial Infarction Complicated Diabetes Mellitus

Impact of Glycometabolic Status on Cardiac Function and Recovery in the Early Phase of Acute Myocardial Infarction

Hemoglobin A1c is Associated with Severity of Coronary Artery Stenosis but Not with Long Term Clinical Outcomes in Diabetic and Nondiabetic Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty

Precise Metabolomics Defines Systemic Metabolic Dysregulation Distinct to Acute Myocardial Infarction Associated With Diabetes

The Significance of Reactive Hyperglycemia in Early Phase of Acute Myocardial Infarction and Its Prognostic Value

Compositional alterations of the gut microbiota in acute myocardial infarction patients with type 2 diabetes mellitus

Impact of Hyperglycemia on Hypersensitive C-reaction Protein, B-type Natriuretic Peptide and Ventricular Remodeling of Elder Patients with Acute Myocardial Infarction